All News about Dexcom Inc
![](https://www.investors.com/wp-content/uploads/2020/02/stock-Dexcom-01-company.jpg)
![](https://mms.businesswire.com/media/20240425938012/en/1474219/22/New_Dexcom_Logo.jpg)
Dexcom Reports First Quarter 2024 Financial Results
April 25, 2024
From DexCom, Inc.
Via Business Wire
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://staticx-tuner.zacks.com/images/articles/charts/54/65329.jpg?v=1424768180)
Via Talk Markets
![](https://www.investors.com/wp-content/uploads/2019/01/stock-ResMed-01-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Analyst Verdict: DexCom In The Eyes Of 4 Experts
April 10, 2024
Via Benzinga
![](https://images.pexels.com/photos/187041/pexels-photo-187041.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
DexCom Inc Chart Analysis
March 26, 2024
Via Talk Markets
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://investorplace.com/wp-content/uploads/2019/07/techstock1600.jpg)
![](https://www.investors.com/wp-content/uploads/2024/04/A1-041524-glucosemonitoring-Gash.jpg)
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-down-red-sell-arrow-bucking-ride-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
DexCom's Options: A Look at What the Big Money is Thinking
March 20, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://g.foolcdn.com/editorial/images/771856/physician-shaking-patients-hand.jpg)
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-to-sell1600.png)
![](https://mms.businesswire.com/media/20240403293559/en/1474219/22/New_Dexcom_Logo.jpg)
![](https://mms.businesswire.com/media/20240402554023/en/1474219/22/New_Dexcom_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401130932_dexcom-stock-gains-from-glp-1-diabetic-users.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/overvalued-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/01/micron_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/770105/march.jpeg)
![](https://www.investors.com/wp-content/uploads/2020/06/Stock-Diabetes-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.